Sejong, South Korea

Jong-Shik Park

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Korea Institute of Oriental Medicine. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jong-Shik Park. Retrieved from https://idiyas.com/inventor/jong-shik-park-6gs4nob1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jong-Shik Park: Innovator in Peripheral Neuropathy Treatment

Introduction

Jong-Shik Park is a notable inventor based in Sejong, South Korea. He has made significant contributions to the field of medicine, particularly in the treatment of peripheral neuropathy. His innovative work focuses on utilizing natural extracts to alleviate the side effects of cancer treatments.

Latest Patents

Jong-Shik Park holds a patent for a composition aimed at the prevention, alleviation, or treatment of peripheral neuropathy. This composition comprises Lithospermi Radix extract as an effective component. The patent highlights the extract's ability to prevent, alleviate, or treat peripheral neuropathy, especially that induced by anti-cancer agents, such as chemotherapy. The method involves administering the composition to individuals in need, showcasing its potential to relieve the suppressed growth of neurites without inducing cytotoxicity in normal cells. Furthermore, the extract can effectively lower the heightened sensitivity to painful stimuli in peripheral neuropathic animals caused by chemotherapy.

Career Highlights

Jong-Shik Park is affiliated with the Korea Institute of Oriental Medicine, where he conducts research and development in traditional medicine. His work emphasizes the integration of natural remedies into modern medical practices, aiming to improve patient outcomes.

Collaborations

He collaborates with esteemed colleagues, including Jin-Mu Yi and Chae Jun Lim, to advance research in the field of peripheral neuropathy and explore innovative treatment options.

Conclusion

Jong-Shik Park's contributions to the treatment of chemotherapy-induced peripheral neuropathy through the use of Lithospermi Radix extract exemplify the potential of natural components in modern medicine. His work not only addresses a significant medical challenge but also paves the way for future innovations in patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…